Could One-Time TB pill delivery stop the spread?

NCT ID NCT07628140

Not yet recruiting Prevention Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study tests a simpler way to give TB preventive therapy to household contacts of TB patients and people living with HIV. Instead of monthly clinic visits, some participants get the full course of pills at once in their community. Researchers want to see if this approach helps more people finish their treatment and reduces TB transmission.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TB preventive therapy (TPT)
What this could lead to: If successful, this could show that giving TB preventive therapy all at once in the community is a better way to help people finish treatment and reduce TB transmission.
What could go wrong: This trial is not yet recruiting and compares two delivery methods, not a new drug. Results may not apply to other settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease latent tuberculosis infection tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV TUBERCULOSIS IDENTIFICATION TUBERCULOSIS PREVENTION

Contacts and locations

Locations

Centre for Family Health Research and Development (CEFERD) located at Jaramogi Oginga Odinga Teaching and Referral Hospital

Kisumu, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.